Chemically modified novel erythropoietin stimulating protein compositions and methods

Details for Australian Patent Application No. 2001255256 (hide)

Owner Amgen Inc.

Inventors Gegg, Colin V.; Kinstler, Olaf Boris; Boone, Thomas Charles; Freeman, Aimee

Agent Shelston IP

Pub. Number AU-B-2001255256

PCT Pub. Number WO01/76640

Priority 09545335 07.04.00 US

Filing date 6 April 2001

Wipo publication date 23 October 2001

Acceptance publication date 13 April 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

13 April 2006 Application Accepted

  Published as AU-B-2001255256

17 August 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001255257

2001255255-THERAPEUTIC COMPOUNDS AND METHODS